[1] Choi W, Kwon SC, Lee WJ, et al. Feasibility and Safety of Mild Therapeutic Hypothermia in Poor-Grade Subarachnoid Hemorrhage: Prospective Pilot Study[J]. J Korean Med Sci, 2017, 32(8):1337-1344. [2] Tanaka K, Kanamaru H, Morikawa A, et al. Central Hypoventilation Syndrome Complicated with Lateral Medullary Infarction after Endovascular Treatment of the Vertebral Artery Dissecting Aneurysm: A Case Report[J]. NMC Case Rep J, 2016, 3(4):133-136. [3] 宋炳伟,甄勇,何亮,等.显微夹闭手术时机对高分级动脉瘤性蛛网膜下腔出血患者预后的影响[J].中国脑血管病杂志,2015,12(7):352-359. [4] 陈璐,王芳.疼痛管理流程在蛛网膜下腔出血重症患者护理中的应用效果[J].中华现代护理杂志,2016,22(16):2287-2290. [5] 谷春平,童岚,周晶,等.两种不同的肠内营养途径在高分级动脉瘤性蛛网膜下腔出血患者中的临床价值探讨[J].中国实验诊断学,2016,20(5):832-833. [6] 马吉芬.护理干预对动脉瘤性蛛网膜下腔出血患者预后及并发症的影响[J].现代中西医结合杂志,2016,25(13):1471-1473. [7] 邱吕琴.“医护合作”式疼痛管理在外伤性蛛网膜下腔出血患者头痛控制中的应用[J].齐鲁护理杂志,2015,21(24):32-34. [8] Mijiti M, Mijiti P, Axier A, et al. Incidence and Predictors of Angiographic Vasospasm, Symptomatic Vasospasm and Cerebral Infarction in Chinese Patients with Aneurysmal Subarachnoid Hemorrhage[J]. PLoS One, 2016, 11(12):e0168657. [9] 刘炎,杭春华,茅磊,等.高分级动脉瘤性蛛网膜下腔出血颅内动脉瘤夹闭术后不同引流方式的疗效及对预后的影响[J].疑难病杂志2017,16(6):623-625. [10] Kilic M, Yilmaz I, Tanriverdi O, et al. Factors that Affect Postoperative Hydrocephalus Development in Aneurysmal Subarachnoid Hemorrhage: A Clinical Study[J]. Turk Neurosurg, 2017, 27(3):353-361. [11] Kozak N, Bereczki D, Szabo S. Predictors of Symptomatic Vasospasm After Subarachnoid Hemorrhage: A Single Center Study of 457 Consecutive Cases[J]. Turk Neurosurg, 2016, 26(4):545-549. [12] 郑匡,田作富,谭显西,等.早期治疗高分级动脉瘤性蛛网膜下腔出血的一年预后因素多中心研究[J].中华外科杂志,2017,54(7):534-539. [13] 杜世正.循证护理实践模式及应用启示.护理学杂志,2016,31(2):87-91. [14] 李帮兰,高阳.循证护理在动脉瘤性蛛网膜下腔出血患者中的应用[J].中国基层医药,2013,20(22):3499-3501. [15] Duan G, Yang P, Li Q, et al. Prognosis Predicting Score for Endovascular Treatment of Aneurysmal Subarachnoid Hemorrhage: A Risk Modeling Study for Individual Elderly Patients[J]. Medicine (Baltimore), 2016, 95(7):e2686. [16] Kumar M, Cao W, McDaniel JK, et al. Plasma ADAMTS13 activity and von Willebrand factor antigen and activity in patients with subarachnoid haemorrhage[J]. Thromb Haemost, 2017, 117(4):691-699. [17] Hamasaki T, Yamada K, Kuratsu J. Seizures as a presenting symptom in neurosurgical patients: a retrospective single-institution analysis[J]. Clin Neurol Neurosurg, 2013, 115(11):2336-2340 [18] Zhang Q, Ma L, Liu Y, et al. Timing of operation for poor-grade aneurysmal subarachnoid hemorrhage: study protocol for a randomized controlled trial[J]. BMC Neurol, 2013, 13(1):108 [19] Park S, Kaffashi F, Loparo KA, et al. The use of heart rate variability for the early detection of treatable complications after aneurysmal subarachnoid hemorrhage[J]. J Clin Monit Comput, 2013, 27(4):385-393. [20] Yang TC, Chang CH, Liu YT, et al. Predictors of shunt-dependent chronic hydrocephalus after aneurysmal subarachnoid haemorrhage[J]. Eur Neurol. 2013, 69(5):296-303.
|